Ever since Biogen and Eisai’s Aduhelm (aducanemab) was approved in 2021 as the first antibody to treat Alzheimer’s disease by ...

Learn how AI and machine learning enhance antibody discovery – from structure prediction to binding optimization – with robust data and lab informatics.

Learn how AI and machine learning enhance antibody discovery – from structure prediction to binding optimization – with robust data and lab informatics.

The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody engineering and optimization.

GLIMPSE-1 was developed as a core component of Infinimmune’s therapeutic development capabilities, strengthening the company’s pipeline of antibody drug candidates. The model was trained using a large ...

Many patent applicants currently face difficulty in obtaining antibody claims because of written description and enablement rejections under 35 U.S.C. §112(a). The USPTO routinely rejects claims ...

The agreement grants GC Cell exclusive rights to utilize DAAN Biotherapeutics' antibody sequence in the research and development of CAR-T (chimeric antigen receptor T cell) and CAR-NK (chimeric ...

The agreement grants GC Cell exclusive rights to utilize DAAN Biotherapeutics' antibody sequence in the research and development of CAR-T (chimeric antigen receptor T cell) and CAR-NK (chimeric ...

Understand the significance of antibodies in adaptive immunity against pathogens. Learn about the combined use of cryo-electron microscopy and mass spectrometry for antibody sequencing and epitope ...

Takeaways CDR scanning is a useful tool and can serve as the basis to provide enablement and written description support for claims scope beyond specific antibody or CDR sequences.

New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers at UZH have now developed a technology that can be used to test around 25 antibodies ...

R&D software developer Dotmatics is rolling out a platform for discovering and developing therapeutic antibodies and proteins. | Geneious Luma aims to focus on monoclonal and multispecific ...